Posted by Michael Wonder on 10 Oct 2022
Federal drug price watchdog consulting public on proposed changes to its pricing guidelines
7 October 2022 - The PMPRB's guidelines explain how its staff monitor and review patented medicine prices to ensure they are not excessive.
The Patented Medicine Prices Review Board released its new draft Guidelines today and launched a 60 day consultation period with stakeholders and interested members of the public.
